ARDX Ardelyx Inc
Company Analysis
Latest News
🔴 Ardelyx is trading 5% down amid biotech-sector weakness
Ardelyx is trading at $3.04, down 5.00%, amid biotech-sector weakness, the clearest available explanation; XBI is down 2.08% in the regular session. - Broader...
🟢 Ardelyx is trading 6.2% up in pre-market amid biotech-sector strength
Ardelyx is trading at $3.41, up 6.23%, with its October 21 pre-market rise coinciding with broader biotech-sector strength. - No clear company-specific...
🟢 Ardelyx is trading 5% up today amid broader biotech-sector strength
Ardelyx is trading at $3.25, up 5.02%, with biotech-sector strength the likeliest context; no clear company-specific catalyst is evident. - XBI is up 2.10%...
🔴 Ardelyx is trading 5% down amid tech-led market weakness
Ardelyx is trading at $3.10, down 5.05%, with tech-sector selling and a rotation away from riskier growth stocks offering the clearest context. - No fresh...
🔴 Ardelyx is trading 5% down today as broader markets weaken
Ardelyx is trading 5.11% down at $3.44, as broader market weakness pressures risk-sensitive equities. - The Nasdaq is down 1.03% and the S&P 500 is down 0.55%,...
Ardelyx Faces Securities Fraud Class Action Lawsuit After Guidance Cut
Ardelyx, Inc. is facing a securities fraud class-action lawsuit, with law firms reminding investors of the upcoming deadline to seek lead plaintiff status. The...
🟢 Ardelyx is trading 11.73% up today in pre-market — no clear catalyst identified
Ardelyx is trading 11.73% up in pre-market at $4.00 after rising from the September 11 close of $3.58, with no clear catalyst identified. - No...
Ardelyx Announces Resignation of Chief Commercial Officer Eric Foster
Ardelyx, Inc. (ARDX) disclosed that Eric Foster has resigned from his position as Chief Commercial Officer to pursue a new opportunity with a pre-commercial...
🟢 Ardelyx is trading 5.25% up in pre-market
Ardelyx is trading 5.25% higher at $4.21, rebounding from its $4.00 close on August 10, 2026; no new company-specific announcement explaining the August 11...
Ardelyx Delivers Record Revenue but Slashes Its Growth Forecast — Can Insurance Gatekeeping Derail a Billion-Dollar Drug Story?
Shares of Ardelyx (ARDX) cratered 21% to $3.84 after the company's August 6 earnings call paired a record revenue quarter with a jarring downgrade to its...
🔴 Ardelyx is trading 14.07% down today after management cut 2026 IBSRELA revenue guidance
Ardelyx is trading 14.07% down at $4.18 after its August 6 earnings report triggered a post-earnings selloff and management cut 2026 IBSRELA revenue guidance...
🔴 Ardelyx is trading 21.15% down today in pre-market after lower IBSRELA revenue guidance
Ardelyx is trading 21.15% down now in pre-market at $3.84 after its August 6, 2026 earnings release lowered full-year IBSRELA revenue guidance to $350...
🟢 Ardelyx is trading 6.4% up today ahead of Q2 earnings report
Ardelyx is trading at $5.33 (6.4% up), extending a modest uptrend ahead of its Q2 2026 earnings report scheduled for August 06, 2026. * Analysts expect a loss...
Ardelyx Inc Q2 2026 Earnings Preview: What Analysts Expect on August 06, 2026
Analysts expect Ardelyx to report a Q2 2026 loss of $0.05 per share on revenue of $108.42 million, while the current stock price of $9.15 remains significantly...
🔴 ARDX is trading 5.1% down today on technical selling and profit-taking
ARDX is trading 5.1% down at $4.96 as technical selling and profit-taking drive a sharp multi-day slide from last week's highs above $6. • The move appears...
🟢 ARDX is trading 6.5% up today as it rebounds from a recent sell-off
ARDX is trading at $5.91 (6.5%) up in pre-market as shares recover from an 8.4% drop recorded on June 26, 2026. • The move comes without fresh...